What We're Reading: Page 56
Industry reads hand-picked by our editors
Feb 20, 2024
Feb 16, 2024
Feb 15, 2024
-
Los Angeles Times
Inside the plan to diagnose Alzheimer’s in people with no memory problems — and who stands to benefit
-
CNN
First frostbite treatment approved by FDA
-
Bloomberg
WuXi AppTec, WuXi Bio Slump as US Lawmakers Seek Formal Probe
-
Fierce Pharma
Lilly, with approval in sight, runs ad about Alzheimer’s impact
Feb 14, 2024
-
The Wall Street Journal
Drug Shortages Trigger FTC Probe
-
Reuters
Biogen gets DOJ subpoena on business operations in foreign countries
-
Politico
There’s a New Life-Saving Vaccine. Why Won’t People Take It?
Feb 13, 2024
-
The Hill
Federal judge tosses PhRMA lawsuit challenging Medicare drug negotiations
-
Reuters
Exscientia fires CEO after probe over relationship with two employees
-
FirstWord Pharma
Otsuka set for $770 million charge on study failure of Alzheimer’s disease agitation drug
-
Financial Times
Blood protein test offers ‘reliable’ Alzheimer’s warning 15 years early
Feb 12, 2024
Feb 09, 2024
-
Reuters
Astrazeneca says Catalent deal shows need for in-house capacity
-
FirstWord Pharma
Synlogic shutters operations after ending phenylketonuria trial
-
Fierce Biotech
Roche to shrink product development team
Previous
